Reproducibility of circulating MicroRNAs in stored plasma samples

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Bertoia, Monica L ^a   Bertrand, Kimberly A ^a,b   Sawyer, Sherilyn J ^b   Rimm, Eric B ^a,b   Mukamal, Kenneth J ^a,c   Jeyaseelan, Kandiah ^d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CRE RECOMBINASE; SMAD PROTEIN; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR POU; TRANSCRIPTION FACTOR SIX1; BIOLOGICAL MARKER; MICRORNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CHICK; CONTROLLED STUDY; EMBRYO; FEMALE; GENE; GENE SEQUENCE; GENETIC RECOMBINATION; GENETIC TRANSCRIPTION; IN VIVO STUDY; ISL1 GENE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; SIX1 GENE; SPINAL GANGLION; TRIGEMINUS GANGLION; ADULT; AGED; BLOOD; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDY; FOLLOW UP; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MIDDLE AGED; PROSPECTIVE STUDY; REPRODUCIBILITY;

ADULT; AGED; BIOMARKERS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS;

EID: 84943329753     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0136665     Document Type: Article

References (27)

1. van Rooij E, Olson EN. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest. 2007; 117: 2369-2376. PMID: 17786230
2. Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res. 2012; 110: 483-495. doi: 10.1161/CIRCRESAHA.111.247452 PMID: 22302755
3. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 2008; 105: 10513-10518. doi: 10.1073/pnas.0804549105 PMID: 18663219
4. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials. 1998; 19: 61-109. PMID: 9492970
5. Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Hennekens CH, Speizer FE. Dietary fat and the risk of breast cancer. N Engl J Med. 1987; 316: 22-28. PMID: 3785347
6. Rimm EB, Giovannucci EL, Willett WC, Colditz GA, Ascherio A, Rosner B, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet. 1991; 338: 464-468. PMID: 1678444
7. Tworoger SS, Hankinson SE. Use of biomarkers in epidemiologic studies: minimizing the influence of measurement error in the study design and analysis. Cancer Causes Control. 2006; 17: 889-899. PMID: 16841256
8. White E. Measurement error in biomarkers: sources, assessment, and impact on studies. IARC Sci Publ. 2011: 143-161.
9. Chu NF, Spiegelman D, Yu J, Rifai N, Hotamisligil GS, Rimm EB. Plasma leptin concentrations and four-year weight gain among US men. Int J Obes Relat Metab Disord. 2001; 25: 346-353. PMID: 11319631
10. Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 1998; 90: 1292-1299. PMID: 9731736
11. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, et al. Circulating microRNAs in patients with coronary artery disease. Circ Res. 2010; 107: 677-684. doi: 10.1161/CIRCRESAHA.109.215566 PMID: 20595655
12. Taurino C, Miller WH, McBride MW, McClure JD, Khanin R, Moreno MU, et al. Gene expression profiling in whole blood of patients with coronary artery disease. Clin Sci (Lond). 2010; 119: 335-343.
13. Meder B, Keller A, Vogel B, Haas J, Sedaghat-Hamedani F, Kayvanpour E, et al. MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic Res Cardiol. 2011; 106: 13-23. doi: 10.1007/s00395-010-0123-2 PMID: 20886220
14. Abdellatif M. Differential expression of microRNAs in different disease states. Circ Res. 2012; 110: 638-650. doi: 10.1161/CIRCRESAHA.111.247437 PMID: 22343558
15. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L, et al. Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet. 2010; 3: 499-506. doi: 10.1161/CIRCGENETICS.110.957415 PMID: 20921333
16. D'Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG, et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J. 2010; 31: 2765-2773. doi: 10.1093/eurheartj/ehq167 PMID: 20534597
17. Li T, Cao H, Zhuang J, Wan J, Guan M, Yu B, et al. Identification of miR-130a, miR-27band miR-210as serum biomarkers for atherosclerosis obliterans. Clin Chim Acta. 2011; 412: 66-70. doi: 10.1016/j.cca.2010.09.029 PMID: 20888330
18. Ward JA, Esa N, Pidikiti R, Freedman JE, Keaney JF, Tanriverdi K, et al. Circulating Cell and Plasma microRNA Profiles Differ between Non-ST-Segment and ST-Segment-Elevation Myocardial Infarction. Fam Med Med Sci Res. 2013; 2: 108. PMID: 24432306
19. Jang JS, Simon VA, Feddersen RM, Rakhshan F, Schultz DA, Zschunke MA, et al. Quantitative miRNA expression analysis using fluidigm microfluidics dynamic arrays. BMC Genomics. 2011; 12: 144. doi: 10.1186/1471-2164-12-144 PMID: 21388556
20. D'Haene B, Mestdagh P, Hellemans J, Vandesompele J. miRNA expression profiling: from reference genes to global mean normalization. Methods Mol Biol. 2012; 822: 261-272. doi: 10.1007/978-1-61779-427-818 PMID: 22144205
21. Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, Speleman F, et al. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol. 2009; 10: R64. doi: 10.1186/gb-2009-10-6-r64 PMID: 19531210
22. Rosner B (2005) Fundamentals of biostatistics. Belmont, CA: Duxbury Press.
23. Shekelle RB, Shryock AM, Paul O, Lepper M, Stamler J, Liu S, et al. Diet, serum cholesterol, and death from coronary heart disease. The Western Electric study. N Engl J Med. 1981; 304: 65-70. PMID: 7442730
24. Tworoger SS, Eliassen AH, Sluss P, Hankinson SE. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol. 2007; 25: 1482-1488. PMID: 17372279
25. Witwer KW Circulating microRNA biomarker studies: pitfalls and potential solutions. Clin Chem. 2015; 61: 56-63. doi: 10.1373/clinchem.2014.221341 PMID: 25391989
26. Leidner RS, Li L, Thompson CL. Dampening enthusiasm for circulating microRNA in breast cancer. PLoS One. 2013; 8: e57841. doi: 10.1371/journal.pone.0057841 PMID: 23472110
27. Haider BA, Baras AS, McCall MN, Hertel JA, Cornish TC, Halushka MK. A critical evaluation of microRNA biomarkers in non-neoplasticdisease. PLoS One. 2014; 9: e89565. doi: 10.1371/journal.pone.0089565 PMID: 24586876